In simple terms, Bionik Laboratories Corp. has 12 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.526% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -2.209%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -2.350%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust -1.092% return, is a testament to Bionik Laboratories Corp.'s adeptness in optimizing resource deployment. Bionik Laboratories Corp.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 6.719%. Furthermore, the proficiency of Bionik Laboratories Corp. in capital utilization is underscored by a remarkable -3.278% return on capital employed.
Stock Prices
Bionik Laboratories Corp.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.1, while its low point bottomed out at $0.1. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Bionik Laboratories Corp.'s stock market.
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
